Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1α)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cells Hiroshi KamiyamaShingo TakanoAkira Matsumura Original Paper 04 December 2004 Pages: 205 - 213
Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation Wichard VogelHans-Georg KoppHermann Einsele Original Paper 23 December 2004 Pages: 214 - 218
Ewing’s sarcoma and primitive neuroectodermal tumor of hand and forearm Wolfgang DaeckeSusanne AhrensLudger Bernd Original Paper 22 December 2004 Pages: 219 - 225
Expression of COX-2 and HER-2/neu and estrogen and progesterone receptor in primary squamous cell carcinomas of the endometrium L.-C. HornS. FaberC. Leo Original Paper 14 December 2004 Pages: 226 - 228
Heparanase expression correlates with malignant potential in human colon cancer T. NobuhisaY. NaomotoN. Tanaka Original Paper 30 December 2004 Pages: 229 - 237
Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population Yasuhiro KomiyaHiromasa TsukinoTakahiko Katoh Original Paper 23 December 2004 Pages: 238 - 242
Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells Claudio FestucciaAdriano AngelucciMauro Bologna Original Paper 14 January 2005 Pages: 243 - 254
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer J. WiereckyC. KollmannsbergerC. Bokemeyer Original Paper 31 December 2004 Pages: 255 - 260
Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter O. PradierK. LedererC. F. Hess Original Paper 23 December 2004 Pages: 261 - 269